Capítulo 10. 2. Intoxicaciones por analgésicos

Bibliografía
 

1. Henretig, FM., Selbst, SM, Forrest, C. Repeated acetaminofen overdose. Clin. Pediatr. 1989; 28: 525.
2. Goodman, A., Goodman, LS, Rall, TW, Murad, F. Las bases farmacológicas de la terapéutica. 7.ª edición; 643-680.
3. Rippe, JM, Irwin, RS, Fink, MP, Cerra, FB Intensive Care Medicine. Third edition. 1487-1495.
4. Rumack BH, Augenstein WL, en Haddad LM, Winchester JF. Clinical management of poisoning and drug overdose. Second edition 1990. pp.893-930.
5. Slattery JT, Wilson JM, Kalhorn TF, et al. Dose-dependent
pharmacokinetics of acetaminophen. Evidence of glutathione depletion in
human. Clin. Pharmacol. Ther. 1987; 41: 413.
6. Prescott LF. Paracetamol overdosage: Pharmacological considerations and clinical management. Drugs. 1983. 25: 290.
7. Linden CH, Rumack BH. Acetaminophen overdose. Emerg Clin North
Am. 1984. 2: 103
8. Goldfinger R, et al. Concomitant alcohol and drug use enhancing
acetaminophen tixicity. Am J Gastroenterol. 1978; 70: 385.
9. Seef L, et al. Acetaminophen hepatotoxicity in alcoholics. Ann Intern Med.1986. 104: 399.
10. Minton NA, Henry JA, Frankel RJ. Fatal paracetamol poisoningin an
epileptic. Hum Toxicol. 1988. 7: 33.
11. Stricker BH, Meyboom RH, Lindquist M. Acute hipersensitivity reactions to paracetamol. Br Med J. 1985. 291: 938.
12. Gabriel R. Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J. 1982. 284: 505
13. Davenport A, Finn R. Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma. Nephron 1988. 50: 55.
14. Coward RA. Paracetamol-induced acute pancreatitis. Br Med J. 1977. 1:1086.
15. Gilmore IT, Touvras E. Paracetamol-induced acute pancreatitis. Br Med J.1977. 2: 753.
16. Sanerkin NG. Acute myocardial necrosis in paracetamol poisoning. Br Med J. 1971. 3: 478 (carta)
17. Flanagan RJ, Mant TGK. Coma and metabolic acidosis early in severe acute paracetamol poisoning. Human Tox. 1986. 5: 179-182.
18. McClean D, et al. Paracetamol and methemoglobinemia. Br Med J. 1968; 1: 390
19. Davidson DGD, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J. 1966. 2: 497.
20. Sporer KA, Khayam-Bashi H. Acetaminophen and salicylate serum levels in patients whith suicidal ingestion or altered mental status. Am J Emerg Med. 1996. 14 (5): 443-446.
21. Okuonghae HO, Ighogboja IS, et al. Diethylene glycol poisoning in
Nigerian children. Ann Trop Paediatr. 1992; 12 (3): 235-238.
22. Rumack BH, Peterson RC, Koch GC, et al. Acetaminophen overdose: 662 cases with evaluation of oral acetylcystein treatment. Arch Intern Med. 1981. 141: 380.
23. Martin J, Smilkstein MJ, Knaap GL, Kulig KW, et al. Efficacy of oral N-acetylcystein in the treatmen of acetaminophen overdose: Analysis of the National Multicenter Study 1976-1985. N Engl J Med. 1988. 319: 1557.
24. Cetaruk EW, Dart RC, Horowitz RS, et al. Extended-release acetaminophen overdose. JAMA. 1996. 275 (9): 686.
25. Cheung L, Potts RG, Meyer KC. Acetaminophen treatment nomogram.N Engl J Med. 1994; 330: 1907-8.
26. Bray GP, Mowat C, Muir DF, et al. The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Hum Exp Toxicol. 1991. 10: 435-438.
27. Eriksson LS, Broomé U, Kalin M, Lindholm M. Hepatotoxicity due to repeated intake of low doses of paracetamol. J Intern Med. 1992; 231: 567-570.
28. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995. 346: 547-552.
29. Douidar SM, Asi-Khalil I, Habersang RW. Severe hepatotoxicity, acute renal failure, and pancytopenia in a young child after repeated acetaminophen overdosing. Clin Pediatr 1994; 33: 42-45.
30. Canalesse J, Gimson AES, Davis M, Williams R. Factors contributing to mortality in paracetamol-induced hepatic failure. BMJ 1981; 282: 199-201.
31. Harrison PM, O´Grady JG, Keays RT, et al. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ 1990; 301: 964-966.
32. O´Grady JG, Alexander GJM, Hayllar KM, et al. Early indicators of
prognosis in fulminant hepatic failure. Gastroenter 1989; 97: 439-445.
33. Jones AF, Harvey JM, Vale JA. Hypophosphataemia and phosphaturia in paracetamol poisoning. Lancet 1989; ii: 608-609.
34. Neuvonen PJ, Vartiainen M, Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol 1983; 24: 557-562.
35. Amitai Y, Mitchell AA, McGuigan MA, Lovejoy FH. Ipecac-induced emesis and reduction of plasma concentrations of drugs following accidental overdose in children. Pediatrics 1987; 80: 364-367.
36. Harrison PM, Wendon JA, Gimson AES, et al. Improvement by
acetylcysteine in hemodynamics and oxigen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-57.
37. Jones AL, Haynes WM, MacGuilchrist AJ, et al. N-acetylcysteine is a potent peripheral vasodilator. Gut 1994; 35: S5 (510).
38. Prescott LF, Illingworth RN, Critchley JAJH, et al. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979; ii: 1097-1100.
39. Smilkstein MJ, Bronstein AC, Linden C, et al. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991; 20: 1058-1063.
40. Prescott LF, Illingworth RN, Critchley JAJH, et al. Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoningÊ . BMJ 1980; 280: 46-47.
41. Sandler DP, Smith JC, Weinberg CR, et al. Anagesic use and chronic renal disease. N Engl J Med 1989. 320: 1238.
42. Harrison PM, Keays R, Bray GP, et al. Improved outcome paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 1572-73.
43. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991; 303: 1026-29.
44. Webb D. Charcoal haemoperfusion in drug intoxication. Br J Hosp Med. 1993; 49 (7): 493-6
45. Larsen FS, Kirkegaard P, Resmussen A, Hansen BA. The Danish Liver Transplantation Program and patients with serious acetaminophen intoxication. Transplant Proceedings. 1995; 27 (6): 3519-20.
46. O´Grady JG, Wendon J, Tan KC, et al. Liver ttransplantation after
paracetamol overdose. BMJ 1991; 303: 221-23.
47. Rippe JM, Irwin RS, Fink MP, Cerra FB. Intensive Care Medicine. Third edition 1996; 1685-92.
48. Alex T, Proudfoot BS. Toxicity of salicylates. AM J Med 1983; 75: 99-103.
49. Gabow PA, Anderson RJ, Potts DE, Schrier RW. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med 1978; 138: 1481.
50. Robert P, Kimberly RP, Plotz, PH. Aspirin-induced depression of renal function. N Engl J Med 1977; 296: 418.
51. Done A K, Temple A R. Treatment of salicylate poisoning. Mod Tret 1971; 8: 528.
52. Treib J, et al. Cerebral infarct in chronic acetylsalicylic acid poisoning. Nervenartz 1996; 67 (4): 333-334.
53. Done AK. Aspirin overdosage: incidence, diagnosis, and management. Pediatr 1978; 62: 890.
54. Kwong TC. Salicylate measurement: clinical usefulness and methodology. CRC Crit Rev Cin Lab Sci 1987; 25: 137.
55. Chapman BJ, et al. Adult salicylate poisoning. Deaths and outcome in patients with high plasma salicylate concentrations. Q J Med 1989; 72:699-707.
56. Dugandzic RM, Tierney MS, Dickinson GE, et al. Evaluation of the validity of the Done Nomogram in the management of acute salicylate intoxication.Ann Emerg Med 1989; 18 (11): 1186-90
57. Done AK. Salicylate intoxication: significance of measurements of salicylate in blood in cases of acute ingestion. Pediatr 1960; 26: 800.
58. Temple AR. Acute and chronics effets of aspirin toxicity and yheir
treatment. Arch Intern Med 1981; 141: 364.
59. Hillman RJ, Prescott LF. Treatment of salicylate poisoning with repeated activated charcoal. BMJ 1985; 291: 1472.
60. Lawson AAH, Proudfoot AT, Brown SS, et al. Forced diuresis in the
treatment of acute salicylate poisoning in adults. Q J Med 1969; 38: 31.
61. Hill JB. Salicylate intoxication. N Engl J Med 1973; 286: 1110.
62. Hill JB. Experimental salicylate poisoning: observations on the effects of altering blood pH on Tissue and plasma salicylate concentrations. Pediatr 1971; 47: 658.
63. Notarianni L. A reassessment of the treatment of salicylate poisoning. Drug Saf. 1992; 7: 292.
64. Strong JE, et al. Phenylbutazone self-poisoning treated by charcoal
haemoperfusion. Anaesthesia 1979; 34: 1038-40.
65. Berlinger WG, et al. Haemoperfusion for phenylbutazone poisoning. Ann Intern Med 1982; 96: 334.
66. Vale JA, Meredith TJ. Acute poisoning due to Non-Steroidal
antiinflammatory drugs: clinical features and management. Med Toxicol
1986; 1: 12-31.
67. Okonek S, Reinecke H. Acute toxicity of pyrazolones. Am J Med 1983; 75: 94-98.
68. Duggan DE, et al. The metabolism of indomethacin in man. Pharmacol
Exp Ther 1972; 181: 563.
69. Hall AH, et al. Ibuprofen overdose: 126 cases. Ann Emerg Med 1986; 15: 1308-13.
70. Hall AH, et al. Ibuprofen overdose: a prospective study. West J Med 1988; 148: 653-6.
71. Court H, Streete P, Volans GN. Acute poisoning with ibuprofen. Human Toxicol 1983; 2: 381-384.
72. Court H, Volans GN. Poisoning after overdose with non-steroidal anti-inflammatory drugs. Adv Drug React AC Pois Rev 1984; 3: 1-21.
73. Bennett R, Dunkelburg JC, Marks ES. Acute oliguric renal failure due to ibuprofen overdose. South Med J 1985; 78: 490.
74. Menzies DG, et al. Fulminant hiperkalaemia and multiple complications following ibuprofen overdose. Med Toxicol Adverse Drug Exp 1989; 4 (6): 468-71.
75. Martínez R, et al. Severe metabolic acidosis after acute naproxen sodium ingestion. Ann Emerg Med 1989; 18: 1102-4.
76. Bond GR, et al. Generalizad seizures and metabolic acidosis after ketoprofen overdose. Vet Hum Toxicol 1989; 31 (4): 369.
77. Doman DB, Goldberg HJ. A case of meclofenamate sodium-induced colitis. Am J. Gastroenterol 1986; 110: 747.
78. Nuki G. Nonsteroidal analgesic anti-inflammatory agents. BMJ 1983; 1: 39.
79. Ginestal R. Libro de texto de Cuidados Intensivos. 1991. p 158.